Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization

Table 3

Aggregates content obtained by SE-UPLC.

Brand	Batch	Aggregates (%)
Herceptin	N3597B013	1.06 ± 0.07
	N35973	0.21 ± 0.02
	B34310	0.22 ± 0.03
Trastuzumab-Probiomed	5423120902	0.39 ± 0.01
	5423120601	1.07 ± 0.03
	5422111201	0.25 ± 0.03

Variation is presented as confidence interval at 95% ().